News
05-30-2015, 03:24 AM
Myriad Genetics, Inc. today announced it will highlight several new clinical studies on its myRisk Hereditary Cancer molecular diagnostic test at the 2015 American Society of Clinical Oncology annual meeting being held in Chicago, Ill.
More... (http://www.news-medical.net/news/20150530/Myriad-Genetics-to-highlight-new-clinical-studies-on-myRisk-Hereditary-Cancer-molecular-diagnostic-test-at-ASCO-2015.aspx)
More... (http://www.news-medical.net/news/20150530/Myriad-Genetics-to-highlight-new-clinical-studies-on-myRisk-Hereditary-Cancer-molecular-diagnostic-test-at-ASCO-2015.aspx)